Arterial ischemic stroke and cerebral venous thrombosis in children: a 12-year Argentinean registry

Acta Haematol. 2006;115(3-4):180-5. doi: 10.1159/000090932.

Abstract

Over a 12-year period, 112 consecutive children with arterial ischemic stroke (AIS) and 38 children with cerebral venous thrombosis (CVT) were prospectively recruited at a single pediatric center in Argentina. One or more underlying clinical conditions were identified in most patients (55%) with AIS and in almost all patients with CVT. Inherited and/or acquired prothrombotic disorders were detected in 17% of the patients with AIS and in 34% of the children with CVT. No associations between factor V Leiden or prothrombin G20210A mutation and children with AIS or CVT were found. Antithrombotic agents (i.e., aspirin, low-molecular-weight heparin and acenocoumarol) were administered without major hemorrhagic complications. In our cohorts, mortality due to the thrombotic episode was 1.8% in children with AIS. No child with CVT died from his or her thrombotic episodes. Three children (3.2%) and 1 adolescent (1.1%) with AIS had thrombotic progression and recurrence, respectively. A large percentage of children with AIS (68%) and CVT (32%) have had some kind of sequels that caused serious disability in approximately half the cases.

MeSH terms

  • Adolescent
  • Argentina
  • Brain Ischemia / drug therapy*
  • Brain Ischemia / genetics
  • Brain Ischemia / mortality
  • Cerebral Infarction / drug therapy*
  • Cerebral Infarction / genetics
  • Cerebral Infarction / mortality
  • Child
  • Child, Preschool
  • Factor V / genetics
  • Female
  • Fibrinolytic Agents / administration & dosage*
  • Fibrinolytic Agents / adverse effects
  • Humans
  • Infant
  • Intracranial Thrombosis / drug therapy*
  • Intracranial Thrombosis / genetics
  • Intracranial Thrombosis / mortality
  • Male
  • Point Mutation
  • Registries*
  • Retrospective Studies

Substances

  • Fibrinolytic Agents
  • factor V Leiden
  • Factor V